GSP Resource Corp. (TSXV:GSPR)

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is June - May.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020
Market Capitalization	4	3	3	2	7	3
Market Cap Growth	94.89%	-8.61%	82.08%	-73.31%	101.33%	104.20%
Enterprise Value	4	3	3	2	6	3
Last Close Price	0.09	0.10	0.15	0.09	0.37	0.23
PB Ratio	1.11	1.15	1.52	0.80	3.25	2.70
P/TBV Ratio	1.11	1.15	1.52	0.80	3.25	2.70
Quick Ratio	1.02	1.68	1.14	11.85	33.10	37.88
Current Ratio	2.11	1.84	1.20	12.30	35.76	43.49
Return on Equity (ROE)	-16.43%	-22.74%	-12.71%	-15.13%	-28.81%	-24.75%
Return on Assets (ROA)	-8.33%	-11.33%	-6.72%	-6.87%	-13.25%	-12.80%
Return on Capital (ROIC)	-8.58%	-11.94%	-7.01%	-6.94%	-13.39%	-13.03%
Earnings Yield	-13.14%	-18.02%	-8.53%	-18.18%	-7.09%	-7.78%
FCF Yield	-28.73%	-24.67%	-8.27%	-51.71%	-13.78%	-16.03%
Buyback Yield / Dilution	-30.61%	-27.99%	-0.01%	-23.05%	-52.68%	-33.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.